FindTrial
Sign In

Non targeted metabonomics study of coronary heart disease based on UHPLC-QTOF/MS and the study on the pathogenesis of coronary heart disease

Non targeted metabonomics study of coronary heart disease based on UHPLC-QTOF/MS and the study on the pathogenesis of coronary heart disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039288
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-10-21
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Coronary artery stenosis group:Nil
Myocardial infarction group:Nil
Normal control group:Nil

Sponsors

Shanghai Tongren Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients suspected of coronary heart disease; 2. Patients aged 55-65 years; 3. Half male and half female patients; 4. Hospitalized patients undergoing elective coronary angiography.

Exclusion criteria

Exclusion criteria: 1. Patients with rheumatic heart disease; 2. Patients with cardiomyopathy and other organic heart diseases; 3. Patients with severe liver and kidney dysfunction; 4. Patients with severe infection; 5. Patients with malignant tumor; 6. Patients with immune system diseases; 7. Patients with connective tissue diseases; 8. Patients with hyperthyroidism; 9. Cushing's syndrome and other metabolic diseases.

Design outcomes

Primary

MeasureTime frame
biomarker;—

Countries

China

Contacts

Public ContactSong Lei

Shanghai Tongren Hospital

848015859@qq.com+86 18817314732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026